Showing results (311-320 of 386) with videos related to
Sort By:
Pageof 39
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2026
IASLC Update on Classification of Pulmonary Neuroendocrine NeoplasmsMary Beth Beasley, Yasushi Yatabe, Mauro Papotti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancerDaniele Generali, Francesca M Buffa, Alfredo Berruti, et al.Genes, Chromosomes & Cancer|September 19, 2014
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk areaMarta Betti, Elisabetta Casalone, Daniela Ferrante, et al.The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoidsDorian R A Swarts, Aldo Scarpa, Vincenzo Corbo, et al.The Journal of Molecular Diagnostics : JMD|April 22, 2021
DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic MimicsLuca Bertero, Luisella Righi, Giammarco Collemi, et al.Endocrine Connections|October 23, 2013
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancerFilomena Cetani, Chiara Banti, Elena Pardi, et al.Proceedings of the National Academy of Sciences of the United States of America|January 20, 2019
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesotheliomaTania Villanova, Iacopo Gesmundo, Valentina Audrito, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2017
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint InhibitorsAntonio Marchetti, Massimo Barberis, Renato Franco, et al.Expert Review of Molecular Diagnostics|March 23, 2019
Recent advances in the molecular landscape of lung neuroendocrine tumorsGiuseppe Pelosi, Fabrizio Bianchi, Paul Hofman, et al.Pathologica|August 31, 2021
Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS NetworkAntonio Marchetti, Mattia Barbareschi, Massimo Barberis, et al.Pageof 39